Fidaxomicin: novel antibiotic for Clostridium difficile infection

Name: Work Video:
Duration: 3 min 30 s
Description: Abstract Fidaxomicin (Dificlir) is a new antibiotic licensed for the treatment of C. difficile infection in adults. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Professor Mark Wilcox discusses its place in treatment.
Steve Chaplin; Mark Wilcox
{'id': 'https://openalex.org/W2004900990', 'doi': 'https://doi.org/10.1002/psb.1002', 'title': 'Fidaxomicin: novel antibiotic for Clostridium difficile infection', 'display_name': 'Fidaxomicin: novel antibiotic for Clostridium difficile infection', 'publication_year': 2013, 'publication_date': '2013-01-01', 'ids': {'openalex': 'https://openalex.org/W2004900990', 'doi': 'https://doi.org/10.1002/psb.1002', 'mag': '2004900990'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/psb.1002', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psb.1002', 'source': {'id': 'https://openalex.org/S150604582', 'display_name': 'Prescriber', 'issn_l': '0959-6682', 'issn': ['0959-6682', '1931-2253'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psb.1002', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5066760936', 'display_name': 'Steve Chaplin', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Steve Chaplin', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5101664224', 'display_name': 'Mark Wilcox', 'orcid': 'https://orcid.org/0000-0002-0686-8092'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Mark Wilcox', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '24', 'issue': '1-2', 'first_page': '12', 'last_page': '14'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11288', 'display_name': 'Clostridium difficile and Clostridium perfringens research', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11288', 'display_name': 'Clostridium difficile and Clostridium perfringens research', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11681', 'display_name': 'Nosocomial Infections in ICU', 'score': 0.9242, 'subfield': {'id': 'https://openalex.org/subfields/2706', 'display_name': 'Critical Care and Intensive Care Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/fidaxomicin', 'display_name': 'Fidaxomicin', 'score': 0.98503286}, {'id': 'https://openalex.org/keywords/antibiotic-therapy', 'display_name': 'Antibiotic Therapy', 'score': 0.514417}, {'id': 'https://openalex.org/keywords/c-difficile', 'display_name': 'C difficile', 'score': 0.44782722}], 'concepts': [{'id': 'https://openalex.org/C2781342628', 'wikidata': 'https://www.wikidata.org/wiki/Q5446672', 'display_name': 'Fidaxomicin', 'level': 5, 'score': 0.98503286}, {'id': 'https://openalex.org/C2994496256', 'wikidata': 'https://www.wikidata.org/wiki/Q27031090', 'display_name': 'Clostridium difficile', 'level': 3, 'score': 0.9070585}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8942539}, {'id': 'https://openalex.org/C501593827', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotics', 'level': 2, 'score': 0.6293369}, {'id': 'https://openalex.org/C2993328841', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotic therapy', 'level': 3, 'score': 0.514417}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.4542426}, {'id': 'https://openalex.org/C3019428505', 'wikidata': 'https://www.wikidata.org/wiki/Q574905', 'display_name': 'C difficile', 'level': 4, 'score': 0.44782722}, {'id': 'https://openalex.org/C89423630', 'wikidata': 'https://www.wikidata.org/wiki/Q7193', 'display_name': 'Microbiology', 'level': 1, 'score': 0.41054764}, {'id': 'https://openalex.org/C523546767', 'wikidata': 'https://www.wikidata.org/wiki/Q10876', 'display_name': 'Bacteria', 'level': 2, 'score': 0.1121811}, {'id': 'https://openalex.org/C2778980435', 'wikidata': 'https://www.wikidata.org/wiki/Q424027', 'display_name': 'Vancomycin', 'level': 4, 'score': 0.08514047}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C2779489039', 'wikidata': 'https://www.wikidata.org/wiki/Q188121', 'display_name': 'Staphylococcus aureus', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/psb.1002', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psb.1002', 'source': {'id': 'https://openalex.org/S150604582', 'display_name': 'Prescriber', 'issn_l': '0959-6682', 'issn': ['0959-6682', '1931-2253'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/psb.1002', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psb.1002', 'source': {'id': 'https://openalex.org/S150604582', 'display_name': 'Prescriber', 'issn_l': '0959-6682', 'issn': ['0959-6682', '1931-2253'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.7}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 1, 'referenced_works': ['https://openalex.org/W1038257701'], 'related_works': ['https://openalex.org/W71505647', 'https://openalex.org/W4250742877', 'https://openalex.org/W4237594728', 'https://openalex.org/W4229911113', 'https://openalex.org/W2417186599', 'https://openalex.org/W2327208893', 'https://openalex.org/W2173359111', 'https://openalex.org/W2083237412', 'https://openalex.org/W1581800443', 'https://openalex.org/W1487701245'], 'abstract_inverted_index': {'Abstract': [0], 'Fidaxomicin': [1], '(Dificlir)': [2], 'is': [3], 'a': [4], 'new': [5], 'antibiotic': [6], 'licensed': [7], 'for': [8], 'the': [9, 25], 'treatment': [10], 'of': [11], 'C.': [12], 'difficile': [13], 'infection': [14], 'in': [15, 42], 'adults.': [16], 'In': [17], 'our': [18], 'New': [19], 'products': [20], 'review,': [21], 'Steve': [22], 'Chaplin': [23], 'presents': [24], 'clinical': [26], 'data': [27], 'relating': [28], 'to': [29], 'its': [30, 40], 'efficacy': [31], 'and': [32, 35], 'adverse': [33], 'events': [34], 'Professor': [36], 'Mark': [37], 'Wilcox': [38], 'discusses': [39], 'place': [41], 'treatment.': [43]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2004900990', 'counts_by_year': [], 'updated_date': '2024-12-24T15:38:08.197168', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
